Genetic Signatures | GSS - Ebitda

Aktienkurs
0.10
Täglich Wechseln
-0.01 -5.00%
Monatlich
-32.14%
Jährlich
-81.73%
Q1 Prognose
0.11




Ebitda Veränderung Datum
Avita Medical AUD -9.69M 12.21M 2025-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Pacific Edge NZD -13.97M 332K 2024-09
Paradigm Biopharmaceuticals AUD -5.86M 3.79M 2024-12
Starpharma Holdings AUD -4.85M 1.73M 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12